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Abstract 1 
The genome of influenza type A virus consists of single-stranded RNAs of negative 2 
polarity.  Progeny viral RNA (vRNA) replicated in the nucleus is nuclear-exported, and 3 
finally transported to the budding site beneath the plasma membrane.  However, the precise 4 
process of the membrane targeting of vRNA is unclear, although viral proteins and 5 
cytoskeleton are thought to play roles.  Here, we have visualized the translocation process of 6 
progeny vRNA using fluorescence in situ hybridization method.  Our results provide an 7 
evidence of the involvement of vesicular trafficking in membrane targeting of progeny vRNA 8 
independent of that of viral membrane proteins. 9 
 10 
Keywords: influenza virus; vesicular trafficking; ribonucleoprotein; fluorescence in situ 11 
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1. Introduction 1 
 2 
Influenza type A virus possesses eight-segmented and single-stranded RNAs of negative 3 
polarity (vRNA) as its genome.  Progeny vRNA is replicated through complementary RNA (cRNA) 4 
in the nucleus [1].  The replicated vRNA forms ribonucleoprotein complexes (designated vRNP) 5 
with viral RNA polymerase proteins (PB1, PB2, and PA) and NP [2].  Progeny vRNP is exported 6 
from the nucleus through the CRM1-dependent pathway by the interaction with M1 and NS2 [3-6].  7 
After the nuclear export, the progeny vRNP reaches the budding site beneath the cell surface, and 8 
finally a set of eight segments of vRNA is incorporated into a progeny virion with other viral 9 
structural proteins, HA, NA, and M2 on the apical plasma membrane [7-9].  The distribution of 10 
viral transmembrane proteins on the apical plasma membrane is believed to determine the budding 11 
site of progeny virion [8, 9].  These viral membrane-associating proteins are targeted to plasma 12 
membrane domains by an exocytic pathway through the trans-Golgi network (TGN).  Although the 13 
apical sorting signal of M2 is yet to be defined, HA, NA, and M2 possess the determinants for 14 
sorting and targeting to the apical plasma membrane [9].  Previously, it is suggested that either viral 15 
factors, HA, NA, and M1, or cytoskeleton elements are involved in the transport of vRNP to the cell 16 
surface [9].  Since M1, is a major viral membrane-associated protein, interacts with vRNP and the 17 
cytoplasmic domain of HA [10-12], it is speculated that vRNP might be tethered to the lipid vesicles 18 
associated with HA and/or NA during the exocytic event via their interaction with M1 [10-12].  19 
However, a genetically engineered virus encoding HA lacking its cytoplasmic tail, which is a 20 
putative M1-interacting domain, hardly reduced the efficiency of virus production [13].  It is 21 
reported that influenza viruses carrying a mutant HA with a basolateral sorting signal are assembled 22 
at apical plasma membrane [14, 15].  Similarly, NA is also shown not to be required for virus 23 
assembly and budding [16].  Furthermore, it is proposed that vRNP is transported to apical plasma 24 
  
4
membrane by itself since NP has intrinsic apical targeting activity [17].  Therefore, the transport 1 
mechanism of progeny vRNP to apical membrane, including the responsible cellular compartment(s), 2 
is still not conclusive. 3 
Here, we visualized the intracellular localization of vRNA in infected cells, in order to 4 
clarify the mechanism of its cytoplasmic localization and membrane targeting.  We found that the 5 
newly synthesized vRNA is localized in a juxta-nuclear region of the cytoplasm of infected cells.  6 
The cytoplasmic vRNA showed similar staining pattern with organelles responsible for the vesicular 7 
trafficking and appeared to be re-distributed in the presence of potent inhibitors of the vesicular 8 
trafficking.  However, the intracellular localization of HA and M1 hardly merged with that of 9 
progeny vRNA in the absence or presence of inhibitors of the vesicular trafficking.  Our results 10 
provide an evidence of the involvement of vesicular trafficking tethered onto the cytoskeleton in 11 
localization and membrane targeting of vRNA, which is independent of the transport pathway of HA 12 
and M1. 13 
 14 
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2. Materials and methods 1 
 2 
2.1. Indirect immunofluorescence assay 3 
 4 
MDCK cells grown on coverslips were rinsed shortly by 4% paraformaldehyde (PFA) in 5 
PBS, and then pre-permeablized with cold-0.25% Triton X-100 in CSK buffer (200 mM pipes [pH 6 
6.8], 0.25% [v/v] Triton X-100, 100 mM NaCl, 300 mM Sucrose, 3 mM MgCl2, 1 mM EGTA) for 3 7 
min on ice.  After being rinsed with CSK buffer, cells were fixed by 4% PFA in PBS for 10 min at 8 
room temperature, and then permeabilized with 0.5% Triton X-100 in PBS for 5 min on ice.  9 
Coverslips were soaked in 1% nonfat dry milk in PBS for 1 h, and then incubated for 1 h with 10 
antibodies where indicated.  After wash with 0.1% (v/v) Tween-20 in PBS, coverslips were 11 
incubated with Alexa Flour 568-conjugated anti-mouse or -rabbit IgG (Invitrogen) for 1 h.  Images 12 
were acquired by confocal laser-scanning microscope (Zeiss). 13 
 14 
2.2. FISH assay 15 
 16 
After the indirect immunofluorescence assays, cells were fixed in 4% PFA for 10 min, and 17 
permeabilized on ice with 0.5% Triton X-100 in PBS for 5 min.  After deproteinization by 18 
incubating at room temperature with 0.2 g/ml of Proteinase K (ProK) in PBS containing 0.1% 19 
Tween-20 for 5 min, cells were re-fixed in 4% PFA for 10 min, and then subjected to stepwise 20 
dehydration in ice-cold 70, 90, and 99.5% ethanol.  The dried coverslips were incubated with a 21 
biotin-labeled RNA probe, which was denatured in a buffer containing 20 mM NaHCO3 and 30 mM 22 
Na2CO3 at 60˚C for 40 min and neutralized by adding equal volume of 3 M sodium acetate 23 
containing 1% acetic acid, for 12 h at 37˚C.  After hybridization, cells were washed with 2x SSC 24 
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containing 50% formamide and subsequently with 2x SSC at 42˚C.  The coverslips were soaked in 1 
5% BSA in 4x SSC containing 0.1% Tween-20 for 30 min at 37˚C, and further incubated with 10 2 
g/ml of avidin-FITC (invitrogen) in 4x SSC containing 0.1% Tween-20 for 30 min at 37˚C.  After 3 
being washed with 4x SSC containing 0.1% Tween-20 at 42˚C, cells were examined by confocal 4 
laser-scanning microscope (Zeiss). 5 
 6 
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3. Results and discussion 1 
 2 
3.1. Visualization of the influenza virus genome by FISH method 3 
 4 
We examined the localization of vRNA with progression of infection by FISH assays.  5 
FISH assays were carried out essentially as previously reported [18] except for deproteinization with 6 
0.2 g/ml of Proteinase K.  The signals of vRNA appeared from 4 hours post infection (hpi) in the 7 
nucleus, where the genome replication takes place (Fig. 1).  Since no signal was found until 2 hpi, 8 
the signals detected by the FISH method are not due to the incoming vRNA.  The strong granular 9 
signals were localized around the nucleus at 6 hpi, whereas these granules were expanded in the 10 
entire cytoplasm with a unique organelle-like distribution pattern after 8 hpi (Fig. 1).  We also 11 
found that the cytoplasmic granules are not formed even at 12 hpi in the presence of leptomycin B, a 12 
potent inhibitor of CRM1 (data not shown).  These indicate that the FISH signals represent the 13 
intracellular localization of newly synthesized vRNA exported from nucleus.  The same results 14 
were obtained for other segments (data not shown). 15 
Further to confirm whether these vRNAs in granules form vRNP complexes, we 16 
counterstained NP.  In order to detect NP bound to vRNA, we performed the indirect 17 
immunofluorescence assay using a monoclonal anti-NP antibody, mAb61A5, which preferentially 18 
recognizes NP on vRNP complexes [19].  Figure 1 indicates that most of FISH signals as 19 
cytoplasmic granules are co-localized with NP bound to vRNA.  Therefore, we conclude that the 20 
vRNA in cytoplasmic granules form vRNP complexes.  The vRNP visualized here could be 21 
destined to be packaged into new virus particles since we also observed the vRNP beneath the apical 22 
plasma membrane with HA in cells fixed with 4% PFA at 6 hpi but not 4 hpi (Supplementary fig. 1). 23 
 24 
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3.2. The localizatioin of vRNP at cellular organelles involved in vesicular trafficking 1 
 2 
To reveal a cellular compartment(s), in which newly synthesized vRNA accumulates, we 3 
observed the localization of cellular organelle by immunostaining using antibodies against marker 4 
proteins: Calnexin is a marker protein for endoplasmic reticulum; Furin for TGN; EEA1 for early 5 
endosome; and M6PR for late endosome (Fig. 2).  The distribution pattern of vRNA was found 6 
similar to that of these organelles.  However, the majority of the vRNA was not co-localized with 7 
ER, early endosome, and late endosome, although a part of vRNA was merged with these organelles.  8 
In contrast, a distinct portion of vRNA was co-localized with the TGN.  Exactly the same results 9 
were observed by using anti-NP antibody, mAb61A5 (data not shown).  In addition, we also found 10 
that vRNP is partially localized with microtubules including the microtubule organizing center (data 11 
not shown).  These results strongly suggest the involvement of the vesicular trafficking system in 12 
the membrane targeting of vRNP along cytoskeleton. 13 
 14 
3.3. Intracellular localization of HA and M1 with vRNP 15 
 16 
Previously, it is speculated that M1, a major viral membrane-associated matrix protein, 17 
tethers vRNP to the exocytic membrane associated with HA and/or NA [10-12].  To address this, 18 
the localization of HA and M1 was compared with that of newly synthesized vRNA (Fig. 3A and 3B).  19 
Along with the progression of infection, HA and M1 became present as cytoplasmic granules from 6 20 
hpi as did newly synthesized vRNA (Fig. 3A and 3B).  However, only a small fraction of HA or M1 21 
was co-localized with vRNA.  This suggests that only a small fraction of vRNP interacts with 22 
exocytic vesicles associated with HA and/or M1 and progeny vRNP is transported to the plasma 23 
membrane through a trafficking pathway independent of that for HA and M1. 24 
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 1 
3.4. The effect of Golgi-disturbing agents on the localization of vRNA and viral proteins 2 
 3 
The TGN is responsible for the transport of membrane proteins and lipid from ER to more 4 
distal compartments.  The delivery of transport vesicles from TGN to plasma membrane undergoes 5 
with a high fidelity, which could be guaranteed by vesicles targeting along cytoskeleton.  Previous 6 
studies showed the interaction of NP and M1 with cytoskeletal components [20, 21] and the 7 
co-localization of NP with microtubule [19].  To reveal the relationship between vesicular 8 
trafficking and membrane targeting of progeny vRNP, the localization of vRNA was examined upon 9 
the treatment with either nocodazole or brefeldin A.  Nocodazole disrupts polymerization of 10 
microtubule and causes fragmentation of TGN, while brefeldin A, a potent inhibitor of the vesicle 11 
formation, causes formation of an extensive TGN tubular network [22].  Therefore, if vRNA is 12 
associated with the vesicular trafficking system, the localization of vRNA might be re-located by the 13 
addition of nocodazole and brefeldin A.  FISH assays were applied to infected cells treated with 14 
nocodazole or brefelidin A.  Fragmented foci and tubular localization of vRNA were found in the 15 
cytoplasm in the presence of nocodazole and brefeldin A, respectively (Fig. 3C).  High resolution 16 
images were provided in Supplementary fig. 2.  The patterns of tubular vRNP structures found 17 
upon BFA treatment were reminiscent of microtubule staining.  However, vRNP was co-localized 18 
partially with microtubule in the absence or presence of BFA (Supplementary fig. 3).  These results 19 
suggest the possible correlation between the vesicular trafficking system and membrane transport of 20 
newly synthesized vRNP.  After the treatment with nocodazole or brefeldin A, newly synthesized 21 
vRNA was hardly found to be co-localized with HA or M1 (Fig. 3C).  These results strongly 22 
suggest that the transport pathway of progeny vRNP in the cytoplasm could be different from that of 23 
HA or M1, both of which are thought to be membrane-targeted through the vesicular trafficking 24 
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system [9, 12].  It is quite likely that the major portion of vRNP is targeted to the plasma membrane 1 
using an exocytic pathway independent of HA and M1, although we cannot completely exclude the 2 
possibility of the involvement of HA and M1 in vRNP transport.  Further to clarify the mechanism 3 
of vRNP transport to the apical membrane, identification of a cellular factor(s) involved in the vRNP 4 
transport is critical. 5 
 6 
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Legends of figures 1 
 2 
Fig. 1.  The intracellular localization of vRNP.  MDCK cells were mock-infected or 3 
infected with influenza virus PR/8/34 strain at moi of 10.  At 2, 4, 6, 8, and 12 hpi, infected MDCK 4 
cells were subjected to indirect immunofluorescence assays using anti-NP antibody (mAb61A5, red).  5 
vRNA was also detected by the FISH method using an RNA probe complementary to the segment 1 6 
vRNA (green).  Magnified image was shown in the window at 6 hpi.  All images were captured at 7 
the equal laser intensity and under the same exposure time by confocal laser-scanning microscope. 8 
 9 
Fig. 2.  The distribution of cellular organelle marker proteins and vRNP.  At 8 hpi, 10 
infected cells were subjected to indirect immunofluorescence assays using anti-Calnexin (ER, red), 11 
anti-Furin (TGN, red), anti-EEA1 (early endosome, red), and anti-M6PR (late endosome, red) 12 
antibodies, respectively, and then vRNA was visualized by the FISH method (green).  Magnified 13 
images were shown in the windows. 14 
 15 
Fig. 3.  The localization of vRNA and viral proteins.  (A and B) Intracellular localization 16 
of HA and M1 with vRNP.  Infected cells were subjected to indirect immunofluorescence assays 17 
with either anti-HA (panel A, red) or anti-M1 (panel B, red) antibodies, and then FISH assays to 18 
visualize vRNA (green).  Magnified images were also shown in the windows at 6 hpi for HA, and 19 
at 8 hpi for M1.  All images were captured at the equal laser intensity and under the same exposure 20 
time by confocal laser-scanning microscope.  (C) The effect of Golgi-disturbing agents on the 21 
localization of vRNA and viral proteins.  At 7 hpi, infected cells were incubated for 1 h in the 22 
presence of either DMSO, 1 g/ml Nocodazole (Noc), or 28 g/ml brefeldin A (BFA).  HA (left 23 
panel, red) and M1 (right panel, red) were detected using either anti-HA and anti-M1 antibodies, 24 
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respectively, and then vRNA was visualized by the FISH method (green). 1 
 2 




Supplementary text 
Materials and Methods 
Biological materials 
Madin-Darby canine kidney (MDCK) cells were grown in minimum essential medium 
(MEM) (Nissui) containing 10% of fetal bovine serum.  MDCK cells were infected with influenza 
virus (A/Puerto Rico/8/34) at multiplicity of infection (moi) of 10 PFU/cell.  After incubation for 1 
h, cells were washed and maintained in serum-free MEM. 
Anti-NP (mAb61A5) [1], anti-HA (C-179, TAKARA), anti-M1 [2, 3], anti-Calnexin 
(Stressgen), anti-Furin (Affinitiy Bio Reagents), anti-Early endosome antigen 1 (EEA1, Becton 
Dickinson), and anti-Mannose 6 phosphate receptor (M6PR, Abcam) antibodies were used in 
immunofluorescence assays. 
 
Preparation of fluorescence in situ hybridization (FISH) probe 
 A single-stranded RNA, which is complementary to the segment 1 vRNA between 
nucleotide sequence positions 1268 and 2341, was synthesized using RiboMAXTM Large Scale RNA 
Production System (Promega) for a probe of FISH assay.  Briefly, PCR product, which was 
amplified from cDNA of segment 1 with specific primers 
5’-TAATACGACTCACTATAGGGAGCAAAAGCAGG-3’ and 
5’-AAGATTGCCCGTAAGCACCTCTT-3’, was transcribed by T7 RNA polymerase in the presence 
of 0.35 mM Biotin-16-UTP (Roche) for 12 h at 37˚C.  The RNA product was digested by DNase I 
(Promega) at 37˚C for 30 min, then purified by RNeasy Mini Kit (QIAGEN) according to the 
manufacture’s procedure.  Purified RNA was partially hydrolyzed in a buffer containing 20 mM 
NaHCO3 and 30 mM Na2CO3 at 60˚C for 40 min, and then neutralized by adding equal volume of 3 
M sodium acetate containing 1% acetic acid.  Further, the digested RNA probe was precipitated 
with ethanol in the presence of salmon sperm DNA and yeast tRNA, and then resolved in a solution 
containing 2x SSC, 50% formamide, and 10% dextran sulfate. 
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Supplementary fig. 1.  Visualization of vRNP and HA beneath apical plasma membrane 
using Z-axis reconstitution.  Infected MDCK cells were fixed in 4% PFA at 4 (upper panels) or 6 
hpi (lower panels).  Immunofluorescence staining was carried out with anti-HA (red), anti-ZO-3 as 
a tight junction marker (blue; Invitrogen), and Alexa Fluor 488-conjugated anti-NP (green; 
mAb61A5) antibodies, and then cells were examined using confocal laser-scanning microscopy.  
Images were obtained either as xy plane (upper panel) or xz plane sections along the indicated dotted 
line in xy-plane images (lower panel) in each time point post infection.  The vRNP were found 
beneath apical plasma membrane with HA at 6 hpi but not at 4 hpi. 
 
Supplementary fig. 2.  High resolution images for the localization of vRNP in the 
presence of Golgi-disturbing agents.  At 7 hpi, infected cells were incubated for 1 h in the presence 
of DMSO, 1 g/ml Nocodazole, or 28 g/ml brefeldin A (BFA) and then subjected to FISH assays.  
DNA was counterstained with TO-PRO-3 (blue). 
 
 Supplementary fig. 3.  The intracellular localization of vRNP and microtubule in the 
presence of BFA.  At 7 hpi, infected cells were incubated for 1 h in the presence of 28 g/ml BFA 
and then subjected to indirect immunofluorescence assays with anti-NP (green; mAb61A5) and 
anti--tubulin (red; Sigma Aldrich) antibodies.  Enlarged images of the indicated area (white box) 
are also shown.  The tubular structures of vRNP partially co-localized with microtubule in the 
presence of BFA. 
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